BridgeMD
New treatment option for Congenital Hearing Loss
Official title Perceptual Evaluation and Rehabilitation System Development for Congenital Hearing Loss
ClinicalTrials.gov ID: NCT07024524
What this study is testing
- What it's testing
- This study aims to establish a novel multimodal evaluation and precision rehabilitation system for patients with congenital hearing loss who have received hearing aids, cochlear implantation, or emerging gene therapy. The proposed system will integrate age-stratified difficulty levels, combined with a gamified interaction platform or software designed to assess and train three core perceptual domains: auditory speech perception, music perception, and spatial hearing capabilities.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 1 to 35. Healthy volunteers may be eligible.
You may be able to join if
- For Congenital Deafness Group: Patients with congenital hearing loss with hearing thresholds ≥65 dB who have received hearing aids, cochlear...
- For Healthy Controls Group: Participants with normal hearing thresholds (≤20 dB) whose age and gender matched to the patient group.
- Mandarin Chinese as the native language. Participants and/or their guardians must provide informed consent before the trial, voluntarily sign a...
- Capable of effective communication with researchers under the guardian's assistance and willing to cooperate and comply with the researchers'...
- Participants and/or their guardians should have a correct understanding of the trial and appropriate expectations regarding potential benefits.
You likely can't join if
- Presence of other otological disorders that may interfere with the surgical outcome or interpretation of study endpoints, such as otitis media...
- Presence of other severe congenital diseases, such as congenital heart disease. Presence of severe systemic diseases or in the acute onset of...
- Individuals with low immunity, a history of immune deficiency or organ transplantation.
- Individuals with a history of neurological, mental disorders, or moderate-to-severe cognitive dysfunction, such as epilepsy, dementia, autism...
- Any other conditions for which the investigators consider the subject unsuitable for participation in this clinical study.
The study team makes the final eligibility decision.
Where it's taking place
- Shanghai, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 1 year to 35 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Shanghai, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.